Qiming, B Capital et al to Enhance Cell Therapy Tech
06 Nov 2025
US$ 20.00
Qiming Venture Partners has led the over Rmb100 m (US$14 m) angel financing round of IVACTA Biotechnology ......
Related Publications
Subscribers’ Weekly...
Listen to Australia/New Zealand Investments (Subscribers' Weekly 07 Nov 2025)...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.